80 FR 38713 - National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 80, Issue 129 (July 7, 2015)

Page Range		38713-38714
FR Document		2015-16503

Federal Register, Volume 80 Issue 129 (Tuesday, July 7, 2015)

[Federal Register Volume 80, Number 129 (Tuesday, July 7, 2015)]
[Notices]
[Pages 38713-38714]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-16503]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Diabetes and Digestive and Kidney Diseases; 
Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Special Emphasis Panel; Time-Sensitive Obesity 
Policy.
    Date: July 24, 2015.
    Time: 1:00 p.m. to 2:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Two Democracy Plaza, 6707 
Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Michele L. Barnard, Ph.D., Scientific Review 
Officer, Review Branch, DEA, NIDDK, National Institutes of Health, 
Room 753, 6707 Democracy Boulevard, Bethesda, MD 20892-2542, (301) 
594-8898, barnardm@extra.niddk.nih.gov.

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Special Emphasis Panel; NIDDK Career Awards 
Review.
    Date: August 3, 2015.
    Time: 11:00 a.m. to 12:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Two Democracy Plaza, 6707 
Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Carol J. Goter-Robinson, Ph.D., Scientific 
Review Officer, Review Branch, DEA, NIDDK, National Institutes of 
Health, Room 748, 6707 Democracy Boulevard, Bethesda, MD 20892-5452, 
(301) 594-7791, goterrobinsonc@extra.niddk.nih.gov.

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Special Emphasis Panel; Review of Data 
Management and Coordinating Center (UO1).
    Date: August 3, 2015.
    Time: 2:00 p.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Two Democracy Plaza, 6707 
Democracy

[[Page 38714]]

Boulevard, Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Maria E. Davila-Bloom, Ph.D., Scientific Review 
Officer, Review Branch, DEA, NIDDK, National Institutes of Health, 
Room 758, 6707 Democracy Boulevard, Bethesda, MD 20892-5452, (301) 
594-7637, davila-bloomm@extra.niddk.nih.gov.

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Special Emphasis Panel; T2D Outcomes Ancillary 
Study.
    Date: August 6, 2015.
    Time: 11:00 a.m. to 1:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Two Democracy Plaza, 6707 
Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Robert Wellner, Ph.D., Scientific Review 
Officer, Review Branch, DEA, NIDDK, National Institutes of Health, 
Room 706, 6707 Democracy Boulevard, Bethesda, MD 20892-5452, 301-
594-4721, rw175w@nih.gov.

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Special Emphasis Panel; Reengineering Organs 
P01.
    Date: August 10, 2015.
    Time: 11:00 a.m. to 1:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Two Democracy Plaza, 6707 
Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Thomas A. Tatham, Ph.D., Scientific Review 
Officer, Review Branch, DEA, NIDDK, National Institutes of Health, 
Room 760, 6707 Democracy Boulevard, Bethesda, MD 20892-5452, (301) 
594-3993, tathamt@mail.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.847, 
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive 
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology 
and Hematology Research, National Institutes of Health, HHS)

    Dated: June 30, 2015.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-16503 Filed 7-6-15; 8:45 am]
BILLING CODE 4140-01-P

Federal Register / Vol. 80, No. 129 / Tuesday, July 7, 2015 / Notices 38713

Dated: June 30, 2015. DEPARTMENT OF HEALTH AND DEPARTMENT OF HEALTH AND
Michelle Trout, HUMAN SERVICES HUMAN SERVICES
Program Analyst, Office of Federal Advisory
Committee Policy. National Institutes of Health National Institutes of Health
[FR Doc. 2015–16525 Filed 7–6–15; 8:45 am]
National Institute of Mental Health; National Institute of Diabetes and
BILLING CODE 4140–01–P
Notice of Closed Meeting Digestive and Kidney Diseases; Notice
of Closed Meetings
Pursuant to section 10(d) of the Pursuant to section 10(d) of the
DEPARTMENT OF HEALTH AND
Federal Advisory Committee Act, as Federal Advisory Committee Act, as
HUMAN SERVICES
amended (5 U.S.C. App.), notice is amended (5 U.S.C. App.), notice is
National Institutes of Health hereby given of a meeting of the hereby given of the following meetings.
National Advisory Mental Health The meetings will be closed to the
National Institute of Mental Health; Council. public in accordance with the
Notice of Closed Meeting The meeting will be closed to the provisions set forth in sections
public in accordance with the 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
Pursuant to section 10(d) of the provisions set forth in sections as amended. The grant applications and
Federal Advisory Committee Act, as 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., the discussions could disclose
amended (5 U.S.C. App.), notice is as amended. The grant applications and confidential trade secrets or commercial
hereby given of the following meeting. property such as patentable material,
the discussions could disclose
and personal information concerning
The meeting will be closed to the confidential trade secrets or commercial
individuals associated with the grant
public in accordance with the property such as patentable material,
applications, the disclosure of which
provisions set forth in sections and personal information concerning would constitute a clearly unwarranted
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., individuals associated with the grant invasion of personal privacy.
as amended. The grant applications and applications, the disclosure of which
the discussions could disclose Name of Committee: National Institute of
would constitute a clearly unwarranted
Diabetes and Digestive and Kidney Diseases
confidential trade secrets or commercial invasion of personal privacy. Special Emphasis Panel; Time-Sensitive
property such as patentable material, Name of Committee: National Advisory Obesity Policy.
and personal information concerning Mental Health Council. Date: July 24, 2015.
individuals associated with the grant Date: August 4, 2015. Time: 1:00 p.m. to 2:00 p.m.
applications, the disclosure of which Time: 2:00 p.m. to 4:00 p.m. Agenda: To review and evaluate grant
would constitute a clearly unwarranted applications.
Agenda: To review and evaluate grant
Place: National Institutes of Health, Two
invasion of personal privacy. applications. Democracy Plaza, 6707 Democracy
Name of Committee: National Institute of Place: National Institutes of Health, Boulevard, Bethesda, MD 20892 (Telephone
Mental Health Special Emphasis Panel; Neuroscience Center, Conference Rooms A1/ Conference Call).
Mental Health Services. A2, 6001 Executive Boulevard, Rockville, MD Contact Person: Michele L. Barnard, Ph.D.,
Date: July 22, 2015. 20852 (Telephone Conference Call). Scientific Review Officer, Review Branch,
Time: 11:00 a.m. to 12:00 p.m. Contact Person: Tracy Waldeck, Ph.D., DEA, NIDDK, National Institutes of Health,
Chief, Extramural Policy Branch, DEA, Room 753, 6707 Democracy Boulevard,
Agenda: To review and evaluate grant
National Institute of Mental Health, NIH, Bethesda, MD 20892–2542, (301) 594–8898,
applications. barnardm@extra.niddk.nih.gov.
Place: National Institutes of Health, Neuroscience Center, 6001 Executive Blvd.,
Room 6160, MSC 9607, Bethesda, MD 20892– Name of Committee: National Institute of
Neuroscience Center, 6001 Executive
9607, 301–443–5047, waldeckt@mail.nih.gov. Diabetes and Digestive and Kidney Diseases
Boulevard, Rockville, MD 20852 (Telephone Special Emphasis Panel; NIDDK Career
Conference Call). Awards Review.
Information is also available on the
Contact Person: Aileen Schulte, Ph.D., Date: August 3, 2015.
Institute’s/Center’s home page: http://
Scientific Review Officer, Division of Time: 11:00 a.m. to 12:00 p.m.
Extramural Activities, National Institute of
www.nimh.nih.gov/about/advisory-
Agenda: To review and evaluate grant
Mental Health, NIH, Neuroscience Center, boards-and-groups/namhc/index.shtml, applications.
6001 Executive Blvd., Room 6140, MSC 9608, where an agenda and any additional Place: National Institutes of Health, Two
Bethesda, MD 20892–9608, 301–443–1225, information for the meeting will be Democracy Plaza, 6707 Democracy
aschulte@mail.nih.gov. posted when available. Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
(Catalogue of Federal Domestic Assistance (Catalogue of Federal Domestic Assistance Contact Person: Carol J. Goter-Robinson,
Program No. 93.242, Mental Health Research Program No. 93.242, Mental Health Research Ph.D., Scientific Review Officer, Review
Grants, National Institutes of Health, HHS) Grants, National Institutes of Health, HHS) Branch, DEA, NIDDK, National Institutes of
Dated: June 30, 2015. Health, Room 748, 6707 Democracy
Dated: June 30, 2015. Boulevard, Bethesda, MD 20892–5452, (301)
Carolyn Baum, 594–7791, goterrobinsonc@
Carolyn A. Baum,
Program Analyst, Office of Federal Advisory extra.niddk.nih.gov.
Program Analyst, Office of Federal Advisory
Committee Policy. Name of Committee: National Institute of
Committee Policy.
[FR Doc. 2015–16502 Filed 7–6–15; 8:45 am] Diabetes and Digestive and Kidney Diseases
[FR Doc. 2015–16501 Filed 7–6–15; 8:45 am]
Special Emphasis Panel; Review of Data
tkelley on DSK3SPTVN1PROD with NOTICES

BILLING CODE 4140–01–P
BILLING CODE 4140–01–P Management and Coordinating Center (UO1).
Date: August 3, 2015.
Time: 2:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy

VerDate Sep<11>2014 20:31 Jul 06, 2015 Jkt 235001 PO 00000 Frm 00053 Fmt 4703 Sfmt 4703 E:\FR\FM\07JYN1.SGM 07JYN1

38714 Federal Register / Vol. 80, No. 129 / Tuesday, July 7, 2015 / Notices

Boulevard, Bethesda, MD 20892 (Telephone SUMMARY: This is notice, in accordance SUPPLEMENTARY INFORMATION: This
Conference Call). with 35 U.S.C. 209 and 37 CFR part 404, technology, and its corresponding
Contact Person: Maria E. Davila-Bloom, that the National Institutes of Health, patent applications, is directed to
Ph.D., Scientific Review Officer, Review
Department of Health and Human methods of treating or preventing spinal
Branch, DEA, NIDDK, National Institutes of
Health, Room 758, 6707 Democracy Services, is contemplating the grant of cord injury or a glial scar by
Boulevard, Bethesda, MD 20892–5452, (301) an exclusive patent license to practice administering an agent that reduces the
594–7637, davila-bloomm@ the following inventions embodied in amount or activity of a 4-sulfacted
extra.niddk.nih.gov. the following patent applications: GalNAc in a chondroitin
Name of Committee: National Institute of HHS Ref. No.: E–214–2012/0 glycosaminoglycan chain, wherein said
Diabetes and Digestive and Kidney Diseases Titled: ‘‘Compositions and Methods for the agent includes human enzyme,
Special Emphasis Panel; T2D Outcomes Treatment of Central Nervous System arylsulfatase B (ARSB). This technology,
Ancillary Study. Injury’’ and its corresponding patent
Date: August 6, 2015. 1. US Provisional Patent Application No.: applications, is also directed to methods
Time: 11:00 a.m. to 1:00 p.m. 61/705,555 HHS Ref. No.: E–214–2012/ of increasing neuron growth,
Agenda: To review and evaluate grant 0–US–01 Filing Date: September 25,
applications. proliferation, or migration by
2012 administering an agent that reduces the
Place: National Institutes of Health, Two 2. PCT Patent Application No.: PCT/
Democracy Plaza, 6707 Democracy amount or activity of a 4-sulfacted
US2013/061693 HHS Ref. No.: E–214–
Boulevard, Bethesda, MD 20892 (Telephone 2012/0–PCT–02 Filing Date: September GalNAc in a chondroitin
Conference Call). 25, 2013 glycosaminoglycan chain, wherein said
Contact Person: Robert Wellner, Ph.D., 3. Australian Patent Application No.: agent includes ARSB. This technology
Scientific Review Officer, Review Branch, 2013–32367 HHS Ref No.: E–214–2012/ may be useful as a means to treat
DEA, NIDDK, National Institutes of Health, 0–AU–03 Filing Date: September 25, paralysis and motor defects induced by
Room 706, 6707 Democracy Boulevard, 2013
Bethesda, MD 20892–5452, 301–594–4721, spinal cord injury, such as by promoting
4. European Patent Application No.: axonal regrowth.
rw175w@nih.gov. 13771750 HHS Ref. No.: E–214–2012/0– The prospective exclusive license will
Name of Committee: National Institute of EP–04 Filing Date: September 25, 2013
Diabetes and Digestive and Kidney Diseases be royalty bearing and will comply with
5. U.S. Patent Application No.: 14/430,850
Special Emphasis Panel; Reengineering HHS Ref. No.: E–214–2012/0–US–06
the terms and conditions of 35 U.S.C.
Organs P01. Filing Date: September 25, 2013 209 and 37 CFR part 404. The
Date: August 10, 2015. prospective exclusive license may be
Time: 11:00 a.m. to 1:00 p.m. to BioAxone Biosciences Incorporated granted unless within thirty (30) days
Agenda: To review and evaluate grant (‘‘BioAxone’’), a company incorporated from the date of this published notice,
applications. under the laws of the State of Delaware the NIH receives written evidence and
Place: National Institutes of Health, Two having an office in at least Cambridge, argument that establishes that the grant
Democracy Plaza, 6707 Democracy Massachusetts, U.S.A. The patent rights
Boulevard, Bethesda, MD 20892 (Telephone of the license would not be consistent
in these inventions have been assigned with the requirements of 35 U.S.C. 209
Conference Call).
Contact Person: Thomas A. Tatham, Ph.D., to the United States of America. and 37 CFR part 404.
Scientific Review Officer, Review Branch, BioAxone is seeking all worldwide Properly filed competing applications
DEA, NIDDK, National Institutes of Health, territories for this license. The field of for a license in response to this notice
Room 760, 6707 Democracy Boulevard, use may be limited to ‘‘Treatment of will be treated as objections to the
Bethesda, MD 20892–5452, (301) 594–3993, human acute and chronic neurological contemplated license. Comments and
tathamt@mail.nih.gov. injuries involving axonal regeneration, objections submitted in response to this
(Catalogue of Federal Domestic Assistance as monotherapy or in combination with notice will not be made available for
Program Nos. 93.847, Diabetes, other therapeutic drugs or medical public inspection and, to the extent
Endocrinology and Metabolic Research; devices’’. permitted by law, will not be released
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology DATES: Only written comments and/or under the Freedom of Information Act,
and Hematology Research, National Institutes applications for a license which are 5 U.S.C. 552.
of Health, HHS) received by the NIH Office of Dated: June 30, 2015.
Dated: June 30, 2015. Technology Transfer on or before Richard U. Rodriguez,
David Clary, August 6, 2015 will be considered. Acting Director, Office of Technology
Program Analyst, Office of Federal Advisory ADDRESSES: Requests for copies of the Transfer, National Institutes of Health.
Committee Policy. patent application, patents, inquiries, [FR Doc. 2015–16500 Filed 7–6–15; 8:45 am]
[FR Doc. 2015–16503 Filed 7–6–15; 8:45 am] comments, and other materials relating BILLING CODE 4140–01–P

BILLING CODE 4140–01–P
to the contemplated exclusive license
should be directed to: Cristina
Thalhammer-Reyero, Ph.D., M.B.A., DEPARTMENT OF HEALTH AND
DEPARTMENT OF HEALTH AND Office of Technology Transfer, National HUMAN SERVICES
HUMAN SERVICES Institutes of Health, 6011 Executive
Boulevard, Suite 325, Rockville, MD National Institutes of Health
National Institutes of Health 20852–3804; Telephone: (301) 435–
Submission for OMB Review; 30-Day
4507; Facsimile: (301) 402–0220; Email:
Prospective Grant of Exclusive Comment Request; Generic Clearance
thalhamc@mail.nih.gov. A signed
To Conduct Voluntary Customer/
tkelley on DSK3SPTVN1PROD with NOTICES

License: Treatment of Acute and confidentiality nondisclosure agreement
Chronic Neurological Injuries Involving Partner Surveys (NLM)
will be required to receive copies of any
Axonal Regeneration patent applications or patents that have SUMMARY: Under the provisions of
AGENCY: National Institutes of Health, not been published or issued by the section 3507(a)(1)(D) of the Paperwork
HHS. United States Patent and Trademark Reduction Act of 1995, the National
Office or the World Intellectual Property Institutes of Health (NIH) has submitted
ACTION: Notice.
Organization. to the Office of Management and Budget

VerDate Sep<11>2014 20:31 Jul 06, 2015 Jkt 235001 PO 00000 Frm 00054 Fmt 4703 Sfmt 4703 E:\FR\FM\07JYN1.SGM 07JYN1

Document Created: 2015-12-15 13:27:42
Document Modified: 2015-12-15 13:27:42

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		July 24, 2015.
FR Citation		80 FR 38713

80 FR 38713 - National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 80, Issue 129 (July 7, 2015)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health